July 3, 2018

VUMC in the news

A roundup of a few recent stories from the press about Vanderbilt University Medical Center.

The U.S. Food and Drug Administration has approved a marijuana-derived drug for the treatment of two rare and serious forms of epilepsy. Robert Carson, MD, PhD, assistant professor of Pharmacology, was interviewed by NPR about the approval.

This CNN story about postural orthostatic tachycardia syndrome (POTS) mentions Vanderbilt’s POTS survey. The story is based around the activism of Super Bowl MVP Nick Foles, whose wife Tori has POTS.

Melinda Buntin, PhD, chair of Health Policy, was quoted in a Forbes piece about the role of hospital consolidation and out-of-network fees on health care costs.

Associated Press reporter Jason Dearen interviewed April Pettit, MD, instructor in Medicine, for a story about her “medical detective” role in diagnosing the 2012 fungal meningitis outbreak.

Reuters Health is covering the Neurology study from David Charles, MD, professor and vice-chair of Neurology, that found deep brain stimulation treatment may slow the progression of Parkinson's tremor in early-stage patients.

Healthline reporter Gigen Mammoser interviewed William Schaffner, MD, professor of Preventive Medicine, about a potential new single-dose flu medicine called baloxavir marboxil (trade name Xofluza).